{"id":"W2606976048","doi":"10.1016/j.eururo.2017.03.037","title":"Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025","year":2017,"lang":"en","type":"article","venue":"European Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health","funders":"","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Internal medicine; Carcinoma; Oncology; Kidney cancer; Urology; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005758549,0.0001357724,0.0007059688,0.0002220983,0.0003571128,0.0008439574,0.0002488028,0.0003136012,0.001563182],"category_scores_gemma":[0.001391993,0.00008329794,0.0009519826,0.0003230676,0.0001482689,0.0005494535,0.0002160596,0.001164066,0.0001900326],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001043796,"about_ca_system_score_gemma":0.001211751,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00248862,"about_ca_topic_score_gemma":0.008090217,"domain_scores_codex":[0.9997261,0.00008021602,0.00002077487,0.00004712671,0.00003769166,0.00008807267],"domain_scores_gemma":[0.9995301,0.0001445384,0.0000909494,0.000019703,0.00004256051,0.0001722074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04702023,0.001650686,0.3354734,0.00156354,0.002368644,0.001769273,0.0005251173,0.00457556,0.0102649,0.002647302,0.01857705,0.5735644],"study_design_scores_gemma":[0.00735474,0.02180548,0.8426729,0.00123674,0.004223244,0.005359303,0.0006278176,0.006101551,0.005398591,0.005494629,0.09960994,0.0001150039],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9518075,0.02791082,0.000484581,0.003508629,0.0004615802,0.0000954721,0.0008613422,0.00006245237,0.01480768],"genre_scores_gemma":[0.9931176,0.002818949,0.0003327455,0.00127364,0.0001430146,0.00003428732,0.00109505,0.00001566991,0.001169123],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00248862,"threshold_uncertainty_score":0.007573307,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009601757548408387,"score_gpt":0.2332804327322882,"score_spread":0.2236786751838798,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}